Lowest-Rated StocksLowest-RatedNASDAQ:CME CME Group (CME) Stock Price, News & Analysis $269.80 -3.52 (-1.29%) As of 10:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About CME Group Stock (NASDAQ:CME) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CME Group alerts:Sign Up Key Stats Today's Range$270.78▼$274.9550-Day Range$267.51▼$287.1052-Week Range$206.44▼$290.79Volume138,187 shsAverage Volume2.32 million shsMarket Capitalization$97.23 billionP/E Ratio26.28Dividend Yield1.85%Price Target$261.93Consensus RatingHold Company Overview CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois. Read More CME Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks85th Percentile Overall ScoreCME MarketRank™: CME Group scored higher than 85% of companies evaluated by MarketBeat, and ranked 263rd out of 936 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingCME Group has received a consensus rating of Hold. The company's average rating score is 2.06, and is based on 4 buy ratings, 9 hold ratings, and 3 sell ratings.Amount of Analyst CoverageCME Group has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about CME Group's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth4.77% Earnings GrowthEarnings for CME Group are expected to grow by 4.77% in the coming year, from $10.49 to $10.99 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CME Group is 26.46, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.03.Price to Earnings Ratio vs. SectorThe P/E ratio of CME Group is 26.46, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 19.01.Price to Earnings Growth RatioCME Group has a PEG Ratio of 4.97. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCME Group has a P/B Ratio of 3.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about CME Group's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.51% of the float of CME Group has been sold short.Short Interest Ratio / Days to CoverCME Group has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CME Group has recently increased by 14.59%, indicating that investor sentiment is decreasing significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldCME Group pays a meaningful dividend of 1.84%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthCME Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of CME Group is 48.40%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, CME Group will have a dividend payout ratio of 45.50% next year. This indicates that CME Group will be able to sustain or increase its dividend.Read more about CME Group's dividend. Sustainability and ESG2.9 / 5Environmental Score-0.26 Percentage of Shares Shorted1.51% of the float of CME Group has been sold short.Short Interest Ratio / Days to CoverCME Group has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CME Group has recently increased by 14.59%, indicating that investor sentiment is decreasing significantly. News and Social Media2.9 / 5News Sentiment1.24 News SentimentCME Group has a news sentiment score of 1.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.86 average news sentiment score of Finance companies.News Coverage This WeekMarketBeat has tracked 44 news articles for CME Group this week, compared to 40 articles on an average week.Search InterestOnly 9 people have searched for CME on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added CME Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, CME Group insiders have sold 279.17% more of their company's stock than they have bought. Specifically, they have bought $72,232.00 in company stock and sold $273,885.00 in company stock.Percentage Held by InsidersOnly 0.30% of the stock of CME Group is held by insiders.Percentage Held by Institutions87.75% of the stock of CME Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CME Group's insider trading history. Receive CME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CME Stock News HeadlinesInsider Purchase: 10% owner at $ECIA.PK Buys 2,000,000 SharesAugust 21 at 9:11 PM | quiverquant.comQStrategic Partnership with CME Group Positions Flutter Entertainment for Growth in U.S. Prediction MarketsAugust 21 at 6:50 AM | tipranks.comThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.August 22 at 2:00 AM | Paradigm Press (Ad)The Outlook For S&P 500 Dividends In August 2025August 20 at 5:57 PM | seekingalpha.comFanDuel teams up with exchange operator CME for event contracts pushAugust 20 at 5:57 PM | reuters.comCME partners with FanDuel to launch event contracts platformAugust 20 at 5:57 PM | msn.comCME Teams with FanDuel to Launch Betting on Financial MarketsAugust 20 at 5:57 PM | msn.comMorning Bid: Who's afraid of a hot PPI?August 16, 2025 | msn.comSee More Headlines CME Stock Analysis - Frequently Asked Questions How have CME shares performed this year? CME Group's stock was trading at $232.23 at the beginning of 2025. Since then, CME shares have increased by 17.7% and is now trading at $273.32. How were CME Group's earnings last quarter? CME Group Inc. (NASDAQ:CME) released its quarterly earnings data on Wednesday, July, 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. The business's quarterly revenue was up 10.4% compared to the same quarter last year. Read the conference call transcript. How will CME Group's stock buyback program work? CME Group's Board of Directors initiated a share buyback program on Thursday, December 5th 2024, which allows the company to buy back $3,000,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 3.4% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's leadership believes its shares are undervalued. Who are CME Group's major shareholders? Top institutional shareholders of CME Group include Vanguard Group Inc. (9.76%), State Street Corp (4.56%), Geode Capital Management LLC (2.55%) and Norges Bank (1.58%). Insiders that own company stock include Terrence A Duffy, Bryan T Durkin, Larry G Gerdes, Julie Holzrichter, Sunil Cutinho, Hilda Harris Piell, Martin J Gepsman, Julie Winkler, Howard J Siegel, Elizabeth A Cook, Terry L Savage, Terry L Savage, Daniel R Glickman, Lynne Fitzpatrick, Ken Vroman, Timothy S Bitsberger, Derek Sammann, Suzanne Sprague, Timothy Francis Mccourt, Jonathan L Marcus, Charles P Carey, Daniel G Kaye, Phyllis M Lockett, Dennis Suskind and William R Shepard. View institutional ownership trends. How do I buy shares of CME Group? Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CME Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that CME Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST). Company Calendar Record date for 6/25 Dividend6/09/2025Ex-Dividend for 6/25 Dividend6/09/2025Dividend Payable6/25/2025Last Earnings7/23/2025Today8/22/2025Record date for 9/25 Dividend9/09/2025Ex-Dividend for 9/25 Dividend9/09/2025Dividend Payable9/25/2025Next Earnings (Estimated)10/22/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Securities Exchanges Sub-IndustrySpecialized Finance Current SymbolNASDAQ:CME CIK1156375 Webwww.cmegroup.com Phone(312) 930-1000Fax312-466-4410Employees3,760Year Founded1848Price Target and Rating Average Price Target for CME Group$261.93 High Price Target$305.00 Low Price Target$198.00 Potential Upside/Downside-4.2%Consensus RatingHold Rating Score (0-4)2.06 Research Coverage16 Analysts Profitability EPS (Trailing Twelve Months)$10.33 Trailing P/E Ratio26.46 Forward P/E Ratio26.06 P/E Growth4.97Net Income$3.53 billion Net Margins58.48% Pretax Margin75.24% Return on Equity14.60% Return on Assets2.61% Debt Debt-to-Equity Ratio0.12 Current Ratio1.02 Quick Ratio1.02 Sales & Book Value Annual Sales$6.44 billion Price / Sales15.29 Cash Flow$11.28 per share Price / Cash Flow24.23 Book Value$76.97 per share Price / Book3.55Miscellaneous Outstanding Shares360,380,000Free Float359,299,000Market Cap$98.50 billion OptionableOptionable Beta0.44 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:CME) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CME Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CME Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.